Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 61,833,552 $ 45,816,289
Investments 78,565,491 14,395,913
Other current assets 63,745 78,869
Total current assets 140,462,788 60,291,071
Operating lease right-of-use asset 254,921 0
Total assets 140,717,709 60,291,071
Liabilities, Current [Abstract]    
Accounts payable, accrued expenses and other current liabilities 2,735,236 2,254,300
In-process R and D accrued expenses 0 3,000,000
Total current liabilities 2,735,236 5,254,300
Operating lease liability - non-current 154,920 0
Total liabilities 2,890,156 5,254,300
Commitments and contingencies (Note 9)
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 6,692,140 and 6,102,560 shares issued and outstanding at December 31, 2025, and December 31, 2024, respectively** [1] 6,692 6,103
Additional paid-in capital 227,199,002 130,787,312
Accumulated other comprehensive income 131,389 35,992
Accumulated deficit (89,509,530) (75,792,636)
Total stockholders’ equity 137,827,553 55,036,771
Total liabilities and stockholders’ equity $ 140,717,709 $ 60,291,071
[1] Information pertaining to number of shares outstanding and per share data gives retroactive effect to a 1 for 5 reverse stock split that became effective on August 12, 2024.